Location History:
- Redondo Beach, CA (US) (2006 - 2015)
- Torrance, CA (US) (2021)
Company Filing History:
4 out of 83 
1 out of 10 Years Active: 2006-2021
Title: The Innovative Contributions of John S. Torday
Introduction: John S. Torday, based in Redondo Beach, California, is a prolific inventor with a total of five patents to his name. His work focuses on developing innovative therapies and compositions aimed at treating lung-related disorders and conditions. Torday's contributions are significant in the field of biomedical research, particularly concerning surfactant production and nicotine-induced lung diseases.
Latest Patents: Among Torday's latest innovations are two noteworthy patents. The first is titled "Compositions and method for administering PPARgamma agonists, surfactant peptides and phospholipids." This invention provides therapeutic compositions designed to address both insufficient surfactant production and issues arising from hyperoxia. Formulated for aerosol delivery during ventilation therapy, these compositions include PPAR gamma agonists, surfactant peptides, and phospholipids, aiming to reduce the severity of respiratory distress syndrome (RDS) in infants while promoting lung maturation in hyperoxic environments.
His second patent, "Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists," explores the critical connection between nicotine exposure and lung injury. Torday’s research reveals how nicotine interrupts molecular signaling within the lung alveolus. By employing specific molecular agents such as PPAR gamma agonists, he posits that it is possible to prevent and even reverse lung damage caused by nicotine.
Career Highlights: John S. Torday has made substantial contributions to healthcare through his positions at esteemed research institutions such as the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. These roles have allowed him to carry out groundbreaking research and facilitate significant advancements in respiratory therapies.
Collaborations: Throughout his career, Torday has collaborated with notable professionals in his field, including Virender Rehan and Frans J. Walther. These partnerships have played a vital role in enhancing the depth and impact of his research, paving the way for innovative solutions in lung health.
Conclusion: John S. Torday's contributions to medical science through his patents and research have positioned him as a forward-thinking innovator in the treatment of lung diseases. His work continues to inspire advancements in therapeutic techniques, demonstrating the importance of innovation in addressing complex health challenges.